DAFNA Capital Management’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-341,779	Closed	-$858K	–	75
2020 Q3	$858K	Sell	341,779 -420,887	-55%	-$3.69M	0.28%	58
2020 Q2	$10.4M	Sell	762,666 -90,872	-11%	-$940K	2.99%	6
2020 Q1	$6.47M	Buy	853,538 +83,000	+11%	+$646K	2.7%	11
2019 Q4	$4.87M	Sell	770,538 -57,500	-7%	-$273K	1.67%	15
2019 Q3	$3.25M	Sell	828,038 -2,500	-0.3%	-$10.7K	1.22%	25
2019 Q2	$4.02M	Buy	830,538 +115,000	+16%	+$654K	1.51%	20
2019 Q1	$5.86M	Hold	715,538	–	–	2.53%	10
2018 Q4	$3.96M	Buy	715,538 +89,800	+14%	+$703K	1.97%	15
2018 Q3	$5.53M	Buy	625,738 +15,000	+2%	+$134K	2.27%	10
2018 Q2	$6.09M	Hold	610,738	–	–	2.85%	8
2018 Q1	$5.82M	Buy	610,738 +475,000	+350%	+$6.64M	2.83%	8
2017 Q4	$2.02M	Hold	135,738	–	–	1.09%	31
2017 Q3	$2.67M	Hold	135,738	–	–	1.66%	20
2017 Q2	$1.95M	Buy	135,738 +65,283	+93%	+$827K	1.39%	25
2017 Q1	$648K	Buy	+70,455	New	+$688K	0.55%	51
2016 Q3	–	Sell	-24,700	Closed	-$185K	–	80
2016 Q2	$185K	Sell	24,700 -41,000	-62%	-$358K	0.15%	80
2016 Q1	$592K	Buy	+65,700	New	+$533K	0.51%	57